NCT07868289

Brief Summary

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by systemic inflammation, fatigue, central sensitization, and chronic pain. While physical exercise is strongly recommended to enhance functional capacity and manage fatigue, heightened central sensitivity and pain often limit adherence and clinical gains. Resonance frequency breathing (paced diaphragmatic breathing at 6 breaths per minute, 0.1 Hz) stimulates the baroreflex and facilitates autonomic regulation, which may alleviate central pain processing. This randomized controlled trial aims to evaluate the effects of resonance frequency breathing added to a standard exercise program compared with exercise alone on central sensitization, pain thresholds, fatigue, pain catastrophizing, functional capacity, respiratory muscle strength, disease activity, and quality of life in patients with SLE. Participants will be randomly allocated to either a Standard Exercise Group or a Standard Exercise + Resonance Breathing Group for an 8-week intervention.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
10mo left

Started Nov 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
23 days until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

October 9, 2026

Status Verified

October 1, 2026

Enrollment Period

7 months

First QC Date

October 5, 2026

Last Update Submit

October 5, 2026

Conditions

Keywords

Resonance Frequency BreathingFatigueQuality of LifePain ThresholdExercise TherapyPain CatastrophizingRespiratory Muscle Strength

Outcome Measures

Primary Outcomes (1)

  • Change in Central Sensitization Inventory (CSI) Score

    The Central Sensitization Inventory (CSI) assesses somatic and emotional symptoms associated with central sensitization. Part A comprises 25 items scored on a 5-point Likert scale ranging from 0 (never) to 4 (always), yielding a total score from 0 to 100. Higher scores indicate greater central sensitization severity, with a score of 40 or higher indicating the presence of central sensitivity syndromes.

    Baseline (Week 0) and post-intervention (Week 8)

Secondary Outcomes (7)

  • Change in Pressure Pain Threshold (PPT)

    Baseline (Week 0) and post-intervention (Week 8)

  • Change in Multidimensional Assessment of Fatigue (MAF) Global Fatigue Index

    Baseline (Week 0) and post-intervention (Week 8)

  • Change in Pain Catastrophizing Scale (PCS) Score

    Baseline (Week 0) and post-intervention (Week 8)

  • Change in Six-Minute Walk Test (6MWT) Distance

    Baseline (Week 0) and post-intervention (Week 8)

  • Change in Respiratory Muscle Strength (MIP and MEP)

    Baseline (Week 0) and post-intervention (Week 8)

  • +2 more secondary outcomes

Study Arms (2)

Standard Exercise Group

ACTIVE COMPARATOR

Participants receive an 8-week multi-component standard exercise program including aerobic exercise, progressive resistance training, range of motion, and stretching exercises. Supervised clinical sessions are conducted twice weekly, complemented by home exercises to achieve 150 minutes of weekly aerobic activity.

Behavioral: Standard Exercise Program

Standard Exercise + Resonance Breathing Group

EXPERIMENTAL

Participants receive the identical 8-week standard exercise program combined with diaphragmatic resonance frequency breathing at 6 breaths per minute (0.1 Hz) with a 4:6 inhalation-to-exhalation ratio using a pursed-lip technique. Breathing practice is performed daily (10-20 min/day), guided by the offline mobile application "Prana Breath" and a printed instructional brochure.

Behavioral: Resonance Frequency BreathingBehavioral: Standard Exercise Program

Interventions

Diaphragmatic paced breathing at 6 breaths per minute (0.1 Hz) with a 4:6 second inhalation-to-exhalation ratio via pursed-lip technique, performed 10-20 minutes daily using the offline mobile application "Prana Breath" under a progressive motor learning framework

Standard Exercise + Resonance Breathing Group

An 8-week structured exercise program comprising aerobic, progressive resistance, joint range of motion, and stretching exercises administered twice weekly under supervision and supported by home activity logs to achieve 150 minutes of weekly aerobic exercise.

Standard Exercise + Resonance Breathing GroupStandard Exercise Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically diagnosed with Systemic Lupus Erythematosus (SLE) according to the 2019 ACR/EULAR classification criteria
  • Aged between 18 and 65 years
  • Central Sensitization Inventory (CSI) score of 40 or higher (CSI \>= 40)
  • Stable medical therapy with no pharmacological regimen changes within the last 3 months
  • Willing and cognitively able to provide written informed consent and adhere to the intervention protocol

You may not qualify if:

  • Presence of severe cardiovascular or pulmonary contraindications that preclude safe participation in exercise or paced breathing training
  • Major surgical operation within the preceding 6 months
  • Current pregnancy
  • Active severe disease flare-up
  • Regular and ongoing practice of structured breathing exercises, pranayama, or yoga

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology

Istanbul, Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lupus Erythematosus, SystemicChronic PainFatigue

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Tuğba Çivi Karaaslan, PT, PhD

    Istanbul University - Cerrahpasa

    STUDY DIRECTOR

Central Study Contacts

Merve Coşan, PT, MSc Candidate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist, MSc Student

Study Record Dates

First Submitted

October 5, 2026

First Posted

October 9, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

October 9, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share

Locations